← Browse by Condition
Medical Condition
advanced malignancies
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for advanced malignancies sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — advanced malignancies Clinical Trials
How many clinical trials are currently recruiting for advanced malignancies?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for advanced malignancies, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for advanced malignancies?
advanced malignancies research spans Phase 1 (3 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a advanced malignancies clinical trial?
Eligibility criteria for advanced malignancies trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04752826 Phase 1, Phase 2
Recruiting
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Enrollment
176 pts
Location
United States, Denma...
Sponsor
BioInvent International AB
NCT06717880 Phase 1
Recruiting
A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
Enrollment
260 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
NCT04651348 Phase 1
Recruiting
A Clinical Study of MIL95 in Advanced Malignancies.
Enrollment
58 pts
Location
China
Sponsor
Beijing Mabworks Biotech Co., ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology